UK markets closed

AstraZeneca PLC (AZNCF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
110.66+2.30 (+2.12%)
At close: 2:24PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
27,583,000
26,617,000
24,384,000
22,090,000
22,465,000
Cost of revenue
5,743,000
5,299,000
4,921,000
4,936,000
4,318,000
Gross profit
21,840,000
21,318,000
19,463,000
17,154,000
18,147,000
Operating expenses
Research development
6,538,000
6,213,000
6,059,000
5,932,000
5,757,000
Selling general and administrative
12,118,000
11,896,000
12,021,000
10,362,000
10,303,000
Total operating expenses
17,471,000
17,624,000
17,761,000
15,644,000
15,855,000
Operating income or loss
4,369,000
3,694,000
1,702,000
1,510,000
2,292,000
Interest expense
1,243,000
1,272,000
1,402,000
1,366,000
713,000
Income before tax
4,589,000
3,916,000
1,548,000
1,993,000
2,227,000
Income tax expense
633,000
772,000
321,000
-57,000
-641,000
Income from continuing operations
3,956,000
3,144,000
1,227,000
2,050,000
2,868,000
Net income
3,977,000
3,196,000
1,335,000
2,155,000
3,001,000
Net income available to common shareholders
3,977,000
3,196,000
1,335,000
2,155,000
3,001,000
Basic EPS
-
2.44
1.03
1.70
2.37
Diluted EPS
-
2.44
1.03
1.70
2.37
Basic average shares
-
1,312,000
1,301,000
1,267,000
1,266,000
Diluted average shares
-
1,313,000
1,301,000
1,267,000
1,267,000
EBITDA
-
8,337,000
6,712,000
7,112,000
5,976,000